Last Update

2016-08-15T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Stephen Squinto?

Dr. Stephen P. Squinto

Executive Vice President, Head of Research and Development

Alexion Pharmaceuticals Inc

Direct Phone: (203) ***-****       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Alexion Pharmaceuticals Inc

100 College Street

New Haven, Connecticut 06510

United States

Company Description

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion is the global leader in complement inhibition and has developed and commercializes the ... more

Find other employees at this company (3,068)

Background Information

Employment History

Venture Partner

OrbiMed Advisors LLC

Affiliations

Board Member
audentes therapeutics, inc.

Board Member
Arvinas Inc

Board Member
New Haven Symphony Orchestra

EXECUTIVE BOARD Member
Lyfebulb Inc

Board Member
TherAchon AG

Lyfebulb Executive Board Member
Social Club

Board of Directors of the Regional Chapter
JDRF

Board Member
Generation UCAN

Co-Founder
Enobia Pharma Inc.

Education

B.A.

Chemistry

Loyola University of Chicago

Ph.D.

Ph.D.

Biochemistry and Biophysics

Loyola University of Chicago

bachelor's degree

chemistry

Loyola University

doctorate degree

biochemistry and biophysics

Loyola University

Web References (199 Total References)


Board of Directors | Arvinas

www.arvinas.com [cached]

Stephen Squinto, Ph.D.

Stephen Squinto, Ph.D., is a Venture Partner with OrbiMed who brings over 25 years of biotechnology industry experience. Dr. Squinto was a co-founder of Alexion Pharmaceuticals, Inc. and recently served as its Executive Vice President and Chief Global Operations Officer. Prior to 2013, he was Alexion's Global Head of Research and Development. From 1988 to 1992, Dr. Squinto held various positions at Regeneron Pharmaceuticals, Inc. Prior to Regeneron, he held a joint academic position at both the Tulane University and LSU Medical Schools. He is a recipient of numerous honors and awards from academic and professional organizations for his scientific work. Dr. Squinto received his B.A. in Chemistry and Ph.D. in Biochemistry and Biophysics from Loyola University of Chicago.


Board of Directors - Audentes Therapeutics

audentestx.com [cached]

Stephen Squinto, Ph.D.

Stephen Squinto, Ph.D., has over 25 years of experience in the biotechnology industry, as both a scientist and senior executive. He is currently a Venture Partner with OrbiMed. Dr. Squinto was a co-founder of Alexion Pharmaceuticals Inc. and recently served as its Executive Vice President and Chief Global Operations Officer. Prior to 2013, he was Alexion's Global Head of Research and Development. Alexion is dedicated to developing therapies for certain rare and ultra-rare diseases. From 1988 to 1992, Dr. Squinto held various positions at Regeneron Pharmaceuticals, Inc. Prior to Regeneron, he held a joint academic position at both the Tulane University and LSU Medical Schools. He is a recipient of numerous honors and awards from academic and professional organizations for his scientific work.
Dr. Squinto received his B.A. in Chemistry and Ph.D. in Biochemistry and Biophysics from Loyola University of Chicago.


Stephen Squinto, ...

lyfebulb.com [cached]

Stephen Squinto, PhD

...
Stephen Squinto, PhD Co-Founder Lyfebulb, Venture Partner Orbimed (Co-founder Alexion)


Audentes Therapeutics Appoints ...

investors.audentestx.com [cached]

Audentes Therapeutics Appoints Stephen Squinto, Ph.d. To Its Board Of Directors

SAN FRANCISCO, CA - April 21, 2015 - Audentes Therapeutics, Inc., a biotechnology company committed to the development and commercialization of gene therapy products for patients with serious, rare diseases, today announced the appointment of Stephen Squinto, Ph.D., to the company's Board of Directors. Dr. Squinto, a co-founder of Alexion Pharmaceuticals, Inc., will serve as an independent director to Audentes."Steve is a pioneer in bringing innovative therapies to patients with rare diseases. A...


Audentes Therapeutics Appoints ...

investors.audentestx.com [cached]

Audentes Therapeutics Appoints Stephen Squinto, Ph.d. To Its Board Of Directors

SAN FRANCISCO, CA - April 21, 2015 - Audentes Therapeutics, Inc., a biotechnology company committed to the development and commercialization of gene therapy products for patients with serious, rare diseases, today announced the appointment of Stephen Squinto, Ph.D., to the company's Board of Directors. Dr. Squinto, a co-founder of Alexion Pharmaceuticals, Inc., will serve as an independent director to Audentes."Steve is a pioneer in bringing innovative therapies to patients with rare diseases. A...

Similar Profiles

Other People with this Name

Other people with the name Squinto

Adam Squinto
The Madison Square Garden Company

Eric Squinto
Burst.com Inc.

Adam Squinto
Loyola University

Stephen Squinto
Mass High Tech

Stephen Squinto

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory